TG Therapeutics (TGTX) Stock Forecast & Price Target

$25.06

-0.07 (-0.28%)

(As of 10/31/2024 ET)

TG Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 7 Analyst Ratings

Sell
0

Hold
1

Buy
6

Based on 7 Wall Street analysts who have issued ratings for TG Therapeutics in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 1 has given a hold rating, and 6 have given a buy rating for TGTX.

Consensus Price Target

$34.43
37.38% Upside

According to the 7 analysts' twelve-month price targets for TG Therapeutics, the average price target is $34.43. The highest price target for TGTX is $50.00, while the lowest price target for TGTX is $20.00. The average price target represents a forecasted upside of 37.38% from the current price of $25.06.

TGTX Analyst Ratings Over Time

Type	Current Forecast 11/2/23 to 11/1/24	1 Month Ago 10/3/23 to 10/2/24	3 Months Ago 8/4/23 to 8/3/24	1 Year Ago 11/2/22 to 11/2/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	6 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$34.43	$31.83	$29.83	$22.25
Forecasted Upside	37.38% Upside	42.24% Upside	61.26% Upside	113.74% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

This is treason (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

TGTX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

TGTX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

TG Therapeutics Stock vs. The Competition

Type	TG Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	2.86	2.79	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	40.12% Upside	15,773.04% Upside	10.09% Upside
News Sentiment Rating	Positive News See Recent TGTX News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/29/2024	TD Cowen 4 of 5 stars	T. Bancroft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$50.00	+105.34%
9/18/2024	HC Wainwright 2 of 5 stars		Reiterated Rating	Buy ➝ Buy	$49.00 ➝ $49.00	+93.83%
8/7/2024	The Goldman Sachs Group 2 of 5 stars		Boost Target	Neutral ➝ Neutral	$18.00 ➝ $20.00	-5.03%
8/7/2024	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$29.00 ➝ $34.00	+61.44%
5/2/2024	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$39.00 ➝ $40.00	+151.89%
4/18/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Overweight	$25.00	+75.93%
5 Stocks that could triple in a week (Ad) Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here. Click here to pay just $5 for a full year of Stealth Trades
11/1/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Buy	$23.00	+106.65%
4/17/2023	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight	$24.00	+16.90%
1/24/2023	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$16.00 ➝ $25.00	+89.54%
12/29/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underperform	$5.00 ➝ $6.00	-40.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:37 AM ET.

TGTX Forecast - Frequently Asked Questions

: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for TG Therapeutics is $34.43, with a high forecast of $50.00 and a low forecast of $20.00.
: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for TG Therapeutics in the last year. There is currently 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TGTX shares.
: According to analysts, TG Therapeutics's stock has a predicted upside of 37.38% based on their 12-month stock forecasts.
: TG Therapeutics has been rated by research analysts at B. Riley, HC Wainwright, TD Cowen, and The Goldman Sachs Group in the past 90 days.
: Analysts like TG Therapeutics more than other "medical" companies. The consensus rating score for TG Therapeutics is 2.86 while the average consensus rating score for "medical" companies is 2.79. Learn more on how TGTX compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

5 Stocks that could triple in a week (Ad)

Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.

Click here to pay just $5 for a full year of Stealth Trades

This page (NASDAQ:TGTX) was last updated on 11/1/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TG Therapeutics (TGTX) Stock Forecast & Price Target